Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Dura, Spiros regulatory update

September 28, 1998 7:00 AM UTC

DURA submitted additional information requested by the FDA to support the NDA for Albuterol Spiros, an inhaler powder form of the asthma drug albuterol. DURA said it provided chemistry and manufacturi...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article